References
- C. Grant, A. Gray, R. Paoletti, et al., Hormone replacement therapy, The Lancet, 354, 152-155 (1999) https://doi.org/10.1016/S0140-6736(99)06570-8
- E. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, W.C. Willett, B. Rosner, EE. Speizer and C.H. Hennekens, Postmenopausal estrogen and progestin use and the risk of cardiovascular disease, N. Engl. J. Med. 335, 453-461 (1996) https://doi.org/10.1056/NEJM199608153350701
- C. Castelo-Branco, M.J. Martinez de Osaba, F. Pons and J. Gonzalez-Merlo, The effect of hormone replacement therapy on postmenopausal bone loss, Eur. J. Obstetr. Gynecol. Reprod. Biol. 44, 131-136 (1992) https://doi.org/10.1016/0028-2243(92)90058-7
- E. Barrett-Connor and D. Gray, Hormone replacement therapy, heart disease, and other considerations, Annu. Rev. Public health, 19, 55-72 (1998) https://doi.org/10.1146/annurev.publhealth.19.1.55
- M.J. Stampfer, G.A. Colditz, W.C. Willett, J.E. Manson, B. Rosner, E.E. Speizer and C.H. Hennekens, Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study, N Engl. J. Med. 325, 756-762 (1991) https://doi.org/10.1056/NEJM199109123251102
- H.K. Genant, J. Lucas, S. Weiss, M. Akin, R. Enkey, H. Mcnaney-Flint, R. Downs, J. Mortola, N. Watts, H.M. Yang, N. Banar, J.J. Brennan and J.C. Nolan, Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study, Arch. Intern. Med. 157, 2609-2615 (1997) https://doi.org/10.1001/archinte.157.22.2609
- T. Holst and B. Salbach, Efficacy of a new 7 -day transdermal sequential estradiol/levonorgestrel patch in women, Maturitas, 41, 231-242 (2002) https://doi.org/10.1016/S0378-5122(01)00297-3
- R. Rossi, G. Origliani and M.G Modena, Transdermal 17-betaestradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women, Diabetes Care. 27, 645-649 (2004) https://doi.org/10.2337/diacare.27.3.645
- M.S. Post, M.J. van der Moorenvan, W.M. Baal, M.A. Blankenstein, H.M. Merkus, M.Y. Kroeks, H.R. Franke, P. Kenemans and CD. Stehouwer, Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: A randomized placebo-controlled study, Am. J. Obstet. Gynecoz. 189, 1221-1227 (2003) https://doi.org/10.1067/S0002-9378(03)00599-4
- E. Weiderpass, H.O. Adami, J.A. Baron, C. Magnusson, R. Bergstrom, A. Lindgren, N. Correia and J. Persson, Risk of endometrial cancer following estrogen replacement with and without progestins, J. Natl. Cancer Inst. 91, 1131-1137 (1999) https://doi.org/10.1093/jnci/91.13.1131
- M. Hori, et al., Classification of percutaneous penetration enhancers. In: R.L. Bronaugh, H.I. Maibach Editors, Percutaneous Absorption: Mechanisms, Methodology, Drug Delivery, Marcel Dekker, New York, USA, pp. 197-211 (1989)
- J.-H. Kim, C.H. Lee and H.-K. Choi, Transdennal delivery of physostigmine: Effects of enhancers and pressure sensitive adhesives, Drug Dev. Ind. Pharm., 28, 833-839 (2002) https://doi.org/10.1081/DDC-120005629
- T. Kokubo, K. Sugibayashi and Y. Morimoto, Interaction between drugs and pressure-sensitive adhesive in transdermal therapeutic systems, Pharm. Res. 11, 104-107 (1994) https://doi.org/10.1023/A:1018906013527
- J.-H. Kim, Y.-J. Cho and H.-K. Choi, Effect of vehicles and pressure sensitive adhesives in the permeation for tacrine across hairless mouse skin, Int. J. Pharm. 196, 105-113 (2000) https://doi.org/10.1016/S0378-5173(99)00449-4
- H.-K. Choi and J.T. Angello, Mathematical analysis and optimization of flow-through diffusion cell system. Pharm. Res. 11, 595-599 (1994) https://doi.org/10.1023/A:1018991221647
- X. Ma, J. Taw and C.M. Chiang, Control of drug crystallization in transdermal matrix system, Int. J. Pharm. 142, 115-119 (1996) https://doi.org/10.1016/0378-5173(96)04647-9
- D.R. Friend and P. Catz, Effect of cosolvents on ethyl acetate enhanced percutaneous absorption of levonorgestrel, J. Control. Release, 12, 171-180 (1990) https://doi.org/10.1016/0168-3659(90)90093-9
- G.S. Chen, D.O. Kim and Y.W. Chien, Dual-controlled transdermal delivery of levonorgestrel and estradiol: enhanced permeation and modulated delivery, J. Control. Release, 34, 129-143 (1995) https://doi.org/10.1016/0168-3659(95)00005-S
-
L.K. Pershing, G.E. Parry and L.D. Lambert, Disparity of in vitro and in vivo oleic acid-enhanced
${\beta}$ -estradiol percutaneous absorption across human skin, Pharm. Res. 10, 1745-1750 (1993) https://doi.org/10.1023/A:1018974131236